Restenosis News and Research

RSS
Restenosis means the reoccurrence of stenosis, a narrowing of a blood vessel, leading to restricted blood flow. Restenosis usually pertains to an artery or other large blood vessel that has become narrowed, received treatment to clear the blockage and subsequently become renarrowed. This is usually restenosis of an artery, or other blood vessel, or possibly a vessel within an organ.
OrbusNeich's Genous Bio-engineered R stent shows safety for percutaneous treatment of coronary artery stenosis

OrbusNeich's Genous Bio-engineered R stent shows safety for percutaneous treatment of coronary artery stenosis

Boston Scientific's TAXUS Element Paclitaxel-Eluting Coronary Stent System launched in Europe

Boston Scientific's TAXUS Element Paclitaxel-Eluting Coronary Stent System launched in Europe

Spectranetics plans multi-center, randomized clinical trial program for in-stent restenosis

Spectranetics plans multi-center, randomized clinical trial program for in-stent restenosis

Medtronic’s Resolute zotarolimus-eluting stent as effective as Xience V everolimus-eluting stent: Study

Medtronic’s Resolute zotarolimus-eluting stent as effective as Xience V everolimus-eluting stent: Study

InspireMD announces next generation MGuard Prime net protective Cobalt Chromium stent system

InspireMD announces next generation MGuard Prime net protective Cobalt Chromium stent system

NEVO Sirolimus-eluting Coronary Stent demonstrates safety and efficacy outcomes at 12 months

NEVO Sirolimus-eluting Coronary Stent demonstrates safety and efficacy outcomes at 12 months

Medtronic announces clinical data presentations on cardiovascular devices at EuroPCR

Medtronic announces clinical data presentations on cardiovascular devices at EuroPCR

BSX receives CE Mark approval for TAXUS Element Paclitaxel-Eluting Coronary Stent System

BSX receives CE Mark approval for TAXUS Element Paclitaxel-Eluting Coronary Stent System

Boston Scientific receives CE Mark approval for TAXUS Element Paclitaxel-Eluting Coronary Stent System

Boston Scientific receives CE Mark approval for TAXUS Element Paclitaxel-Eluting Coronary Stent System

Zilver PTX Drug-Eluting Peripheral Stent safe and effective for treating SFA lesions

Zilver PTX Drug-Eluting Peripheral Stent safe and effective for treating SFA lesions

Tryton Medical widens European availability of Side Branch Stent System

Tryton Medical widens European availability of Side Branch Stent System

Magnetically guided nanoparticles for delivering DNA, cells and drugs

Magnetically guided nanoparticles for delivering DNA, cells and drugs

New study may help devise better treatment strategies for cancer and heart disease

New study may help devise better treatment strategies for cancer and heart disease

ChemoCentryx undertakes Phase II clinical trial of CCX140

ChemoCentryx undertakes Phase II clinical trial of CCX140

Bailout stenting successful treatment for infants with constricted aortas

Bailout stenting successful treatment for infants with constricted aortas

OrbusNeich's Genous Bio-engineered R stent demonstrates long term clinical efficacy

OrbusNeich's Genous Bio-engineered R stent demonstrates long term clinical efficacy

Drug-eluting stents offer new hope to patients with critical limb ischemia

Drug-eluting stents offer new hope to patients with critical limb ischemia

Boston Scientific announces results from HORIZONS AMI trial assessing Express bare-metal stent

Boston Scientific announces results from HORIZONS AMI trial assessing Express bare-metal stent

American College of Cardiology and HOS establish strategic partnership

American College of Cardiology and HOS establish strategic partnership

Tryton Medical announces implantation of Tryton stent for the first time in Portugal and Austria

Tryton Medical announces implantation of Tryton stent for the first time in Portugal and Austria